Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
896.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (0.222%)
Market Cap: £128.91b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

SREP Capital Requirements 2025

31 Oct 2025 07:00

RNS Number : 5906F
Banco Santander S.A.
30 October 2025
 

Banco Santander, S.A., ("Santander") communicates the following: 

OTHER RELEVANT INFORMATION

Santander has been informed by the European Central Bank ("ECB"), after following its Supervisory Review and Evaluation Process ("SREP"), of its decision regarding the minimum prudential capital requirements effective as of 1 January 2026.

The ECB's decision maintains an unchanged Pillar 2 requirement ("P2R") of 1.74% at a consolidated level, of which at least 0.98% must be covered with Common Equity Tier 1 capital ("CET1"). 9 basis points of P2R reflect the capital add-on due to the ECB's prudential expectations on calendar provisioning in connection with non-performing loans.

The following table shows the minimum CET1 and total capital requirements applicable at the consolidated level as of 1 January 2025 and as of 1 January 2026, as well as Santander's ratios[1] as of 30 September 2025:

Minimum Requirement

Data

 

As of 01/01/2025

As of 01/01/2026

As of 30/09/2025

 

CET1

9.65[2]%

9.85%[3]

13.09%

 

Total Capital

13.912%

14.11%[4]

17.43%

 

The increase in the minimum requirements applicable both to CET1 and total capital as of 1 January 2026, compared to those in force since 1 January 2025, amounts to 20 basis points. This increase is due to changes in the systemic risk buffer requirement (3 basis points) and the countercyclical capital buffer requirement (17 basis points)3.

 

As described in the table above, Santander maintains a surplus of capital over these requirements, both in CET1 and total capital terms. 

 

Boadilla del Monte (Madrid), 30 October 2025

 

IMPORTANT INFORMATION

 

Not a securities offer

This document and the information it contains does not constitute an offer to sell nor the solicitation of an offer to buy any securities.

 

Past performance does not indicate future outcomes

Statements about historical performance or growth rates must not be construed as suggesting that future performance, share price or results (including earnings per share) will necessarily be the same or higher than in a previous period. Nothing in this document should be taken as a profit and loss forecast.


[1] Phased-in ratios.

[2] Requirements as of 1 January 2025 considering final figures as of 31 December 2024.

[3] The minimum requirement ratio of CET1 at consolidated level consists of: (a) the minimum capital requirement of Pillar 1 (4.50%), (b) P2R (0.98%), (c) the capital conservation buffer (2.50%), (d) the requirement arising from the consideration of Santander as Other Systemically Important Institution ("OSII"), which has been fixed by Banco de España effective on 1 January 2026 (1.25%), (e) the systemic risk buffer requirement (0.0628%) calculated as of 30 September, and (f) the countercyclical capital buffer requirement (0.4331%) estimated as of 30 September, which must be increased from 1 October 2025 as a result of the activation of 0.50% over the exposures located in Spain (0.12%), and again from 1 October 2026, due to an additional increase of 0.50% over such exposures.

[4] In addition to the CET1 requirement, the minimum total capital requirement at consolidated level includes: (i) Pillar 1 requirements of Additional Tier 1 (1.5%) and Tier 2 (2%), and (ii) part of the P2R requirements which can be covered by Additional Tier 1 and Tier 2 (0.33% y 0.44%, respectively), remaining unchanged with respect to the minimum requirement applicable as of 1 January 2025, save for the CET1 increase of 20 basis points specified above.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMMBPTMTIJBAA
Date   Source Headline
10th Jun 20268:35 amRNSResult of Tender Offer
5th Jun 20263:06 pmRNSDirector/PDMR Shareholding
4th Jun 202611:05 amRNSBuyback programme: transactions 28May-3June
1st Jun 20264:47 pmRNSTotal Voting Rights
28th May 20267:00 amRNSAT1s Contingent Convertible securities
27th May 20268:26 amRNSOffer to purchase outstanding instruments
27th May 20268:21 amRNSResumption of the share buyback programme
13th May 20263:03 pmRNSRating granted by Fitch Ratings
6th May 20263:08 pmRNSDirector/PDMR Shareholding
1st May 20267:08 amRNSFurther re: Santander to acquire TSB
30th Apr 20264:59 pmRNSTotal Voting Rights
29th Apr 20267:00 amRNS1Q2026 Financial report & Earnings presentation
29th Apr 20267:00 amRNSFirst Quarter 2026 Results - Press release
24th Apr 202611:14 amRNSBuyback programme: transactions 16-23Apr
23rd Apr 20267:40 amRNSProspectus Exemption
23rd Apr 20267:25 amRNSTemporary suspension of the share buyback program
22nd Apr 202611:09 amRNS1st Quarter 2026 Results Notice
16th Apr 202611:04 amRNSBuyback programme: transactions 8-15Apr
14th Apr 20264:58 pmRNSSantander informs of the MREL determined by SRB
8th Apr 202611:07 amRNSBuyback programme: transactions 26Mar-7Apr
31st Mar 20264:44 pmRNSTotal Voting Rights
27th Mar 20262:26 pmRNS2026 AGM - Resolutions
27th Mar 20267:06 amRNSSantander expects higher profit&reaffirms targets
26th Mar 202610:12 amRNSBuyback programme: transactions 19-25Mar
19th Mar 20265:01 pmRNSDirector/PDMR Shareholding
19th Mar 202611:17 amRNSBuyback programme: transactions 12-18Mar
13th Mar 20264:37 pmRNSDirector/PDMR Shareholding
12th Mar 202611:10 amRNSBuyback programme: transactions 5-11Mar
9th Mar 202611:17 amRNSDirector/PDMR Shareholding
9th Mar 202611:14 amRNSDirector/PDMR Shareholding
6th Mar 20264:18 pmRNSDirector/PDMR Shareholding
5th Mar 202611:16 amRNSBuyback programme: transactions 27Feb-4Mar
4th Mar 20265:58 pmRNSDirector/PDMR Shareholding
2nd Mar 20265:57 pmRNSTotal Voting Rights
27th Feb 202611:18 amRNSBuyback programme: transactions 19-26Feb
25th Feb 20266:01 pmRNSNotice of AGM
25th Feb 20265:20 pmRNS2025 UK Annual Report
25th Feb 20262:19 pmRNSInvestor Day: Group CFO presentation
25th Feb 202612:42 pmRNSInvestor Day: Group CEO presentation
25th Feb 202612:37 pmRNSInvestor Day: Executive chair presentation
25th Feb 20267:03 amRNSStrategic plans, profit forecasts & payout policy
25th Feb 20267:00 amRNSDividend declaration & agreement to call 2026 AGM
24th Feb 20263:05 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:54 pmRNSDirector/PDMR Shareholding
19th Feb 202611:29 amRNSBuyback programme: transactions 12-18Feb
18th Feb 20264:48 pmRNSDirector/PDMR Shareholding
18th Feb 202611:07 amRNSInvestor Day meeting announcement
12th Feb 20263:02 pmRNSBuyback programme: transactions 4-11Feb
10th Feb 20265:09 pmRNSChanges to the presentation of Group’s information
5th Feb 20265:34 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.